Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2001 Dec;60(12):1103–1109. doi: 10.1136/ard.60.12.1103

Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables

I Gilboe 1, T Kvien 1, T Uhlig 1, G Husby 1
PMCID: PMC1753445  PMID: 11709451

Abstract

OBJECTIVE—Firstly, to study the prevalence of ocular and oral sicca symptoms, reduced tear and saliva production, and the minimum frequency of secondary Sjögren's syndrome (sSS) in systemic lupus erythematosus (SLE). Secondly, to compare sicca symptoms and findings with those of matched patients with rheumatoid arthritis (RA), and sicca symptoms with those in healthy controls. Finally, to study possible associations of clinical variables with sicca symptoms and sSS in SLE.
METHODS—Self reported sicca symptoms were recorded in 81 patients with SLE aged ⩽70, 81 matched patients with RA, and 81 matched healthy controls. Other study variables included Schirmer-I test (S1T), unstimulated whole saliva, health status measures (in SLE and RA), disease activity, accumulated organ damage, and serological markers (in SLE).
RESULTS—A significantly higher proportion of patients with SLE reported sicca symptoms than healthy controls. Further, a significantly higher proportion reported ocular sicca symptoms (43 and 21%, respectively) and had pathologically reduced S1T compared with RA (46 and 21%, respectively). No difference was seen in oral sicca symptoms and saliva production. In SLE, sicca symptoms were associated with fatigue, and sSS with anti-SSB or anti-SSA antibodies, or both.
CONCLUSIONS—An increased prevalence of sicca symptoms was found in patients with SLE compared with controls, and a higher prevalence of ocular sicca symptoms and reduced tear production in SLE compared with RA. Sicca problems should be considered in the care of patients with SLE, especially those with anti-SSB and/or anti-SSA antibodies who have sicca symptoms and fatigue.



Full Text

The Full Text of this article is available as a PDF (155.4 KB).

Figure 1  .

Figure 1  

Proportions of matched patients with SLE and RA with one or more sicca symptoms, pathological reduced Schirmer-I test (S1T), and unstimulated whole saliva (UWS), keratoconjunctivitis sicca, xerostomia, and secondary Sjögren's syndrome (sSS). Keratoconjuntivitis sicca = one or more eye sicca symptoms in combination with pathological S1T; xerostomia = one or more mouth sicca symptoms in combination with pathological UWS. *p<0.05 SLE v RA (McNemar test).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón-Segovia D., Ibáez G., Velázquez-Forero F., Hernández-Ortíz J., González-Jiménez Y. Sjögren's syndrome in systemic lupus erythematosus. Clinical and subclinical manifestations. Ann Intern Med. 1974 Nov;81(5):577–583. doi: 10.7326/0003-4819-81-5-577. [DOI] [PubMed] [Google Scholar]
  2. Andonopoulos A. P., Drosos A. A., Skopouli F. N., Acritidis N. C., Moutsopoulos H. M. Secondary Sjögren's syndrome in rheumatoid arthritis. J Rheumatol. 1987 Dec;14(6):1098–1103. [PubMed] [Google Scholar]
  3. Andonopoulos A. P., Drosos A. A., Skopouli F. N., Moutsopoulos H. M. Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study. Clin Exp Rheumatol. 1989 Mar-Apr;7(2):203–205. [PubMed] [Google Scholar]
  4. Andonopoulos A. P., Skopouli F. N., Dimou G. S., Drosos A. A., Moutsopoulos H. M. Sjögren's syndrome in systemic lupus erythematosus. J Rheumatol. 1990 Feb;17(2):201–204. [PubMed] [Google Scholar]
  5. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  6. Bell D. A. SLE in the elderly--is it really SLE or systemic Sjögren's syndrome? J Rheumatol. 1988;15(5):723–724. [PubMed] [Google Scholar]
  7. Ben-Aryeh H., Gordon N., Szargel R., Toubi E., Laufer D. Whole saliva in systemic lupus erythematosus patients. Oral Surg Oral Med Oral Pathol. 1993 Jun;75(6):696–699. doi: 10.1016/0030-4220(93)90425-4. [DOI] [PubMed] [Google Scholar]
  8. Bombardier C., Gladman D. D., Urowitz M. B., Caron D., Chang C. H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 Jun;35(6):630–640. doi: 10.1002/art.1780350606. [DOI] [PubMed] [Google Scholar]
  9. Brown C. C. The parotid puzzle: a review of the literature on human salivation and its applications to psychophysiology. Psychophysiology. 1970 Jul;7(1):65–85. doi: 10.1111/j.1469-8986.1970.tb02277.x. [DOI] [PubMed] [Google Scholar]
  10. Brun J. G., Jacobsen H., Kloster R., Cuida M., Johannesen A. C., Høyeraal H. M., Jonsson R. Use of a sicca symptoms questionnaire for the identification of patients with Sjögren's syndrome in a heterogeneous hospital population with various rheumatic diseases. Clin Exp Rheumatol. 1994 Nov-Dec;12(6):649–652. [PubMed] [Google Scholar]
  11. Conner S., Iranpour B., Mills J. Alteration in parotid salivary flow in diabetes mellitus. Oral Surg Oral Med Oral Pathol. 1970 Jul;30(1):55–59. doi: 10.1016/0030-4220(70)90011-3. [DOI] [PubMed] [Google Scholar]
  12. Dafni U. G., Tzioufas A. G., Staikos P., Skopouli F. N., Moutsopoulos H. M. Prevalence of Sjögren's syndrome in a closed rural community. Ann Rheum Dis. 1997 Sep;56(9):521–525. doi: 10.1136/ard.56.9.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res. 1987 Feb;66(Spec No):648–653. doi: 10.1177/00220345870660S107. [DOI] [PubMed] [Google Scholar]
  14. Friedlaender M. H. Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca. Rheum Dis Clin North Am. 1992 Aug;18(3):591–608. [PubMed] [Google Scholar]
  15. Gilboe I. M., Kvien T. K., Husby G. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol. 1999 Aug;26(8):1694–1700. [PubMed] [Google Scholar]
  16. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., Bacon P., Bombardieri S., Hanly J., Hay E. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996 Mar;39(3):363–369. doi: 10.1002/art.1780390303. [DOI] [PubMed] [Google Scholar]
  17. Gladman D., Urowitz M., Fortin P., Isenberg D., Goldsmith C., Gordon C., Petri M. Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol. 1996 Nov;23(11):1953–1955. [PubMed] [Google Scholar]
  18. Grennan D. M., Ferguson M., Ghobarey A. E., Williamson J., Dick W. C., Buchanan W. W. Sjogren's syndrome in SLE: Part 2. An examination of the clinical significance of Sjogren's syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma. N Z Med J. 1977 Oct 26;86(598):376–379. [PubMed] [Google Scholar]
  19. Grennan D. M., Ferguson M., Williamson J., Mavrikakis M., Dick W. C., Buchanan W. W. Sjogren's syndrome in SLE: Part I. The frequency of the clinical and subclinical features of Sjogren's syndrome in patients with SLE. N Z Med J. 1977 Oct 26;86(598):374–376. [PubMed] [Google Scholar]
  20. Gutman D., Ben-Aryeh H. The influence of age on salivary content and rate of flow. Int J Oral Surg. 1974;3(5):314–317. doi: 10.1016/s0300-9785(74)80069-4. [DOI] [PubMed] [Google Scholar]
  21. HEATON J. M. Sjögren's syndrome and systemic lupus erythematosus. Br Med J. 1959 Feb 21;1(5120):466–469. doi: 10.1136/bmj.1.5120.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hay E. M., Thomas E., Pal B., Hajeer A., Chambers H., Silman A. J. Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis. 1998 Jan;57(1):20–24. doi: 10.1136/ard.57.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Jacobsson L. T., Axell T. E., Hansen B. U., Henricsson V. J., Larsson A., Lieberkind K., Lilja B., Manthorpe R. Dry eyes or mouth--an epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome. J Autoimmun. 1989 Aug;2(4):521–527. doi: 10.1016/0896-8411(89)90185-6. [DOI] [PubMed] [Google Scholar]
  24. Jacobsson L., Hansen B. U., Manthorpe R., Hardgrave K., Neas B., Harley J. B. Association of dry eyes and dry mouth with anti-Ro/SS-A and anti-La/SS-B autoantibodies in normal adults. Arthritis Rheum. 1992 Dec;35(12):1492–1501. doi: 10.1002/art.1780351213. [DOI] [PubMed] [Google Scholar]
  25. Jensen J. L., Bergem H. O., Gilboe I. M., Husby G., Axéll T. Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus. J Oral Pathol Med. 1999 Aug;28(7):317–322. doi: 10.1111/j.1600-0714.1999.tb02047.x. [DOI] [PubMed] [Google Scholar]
  26. Jonsson H., Nived O., Sturfelt G., Norberg R. Symptomatic secondary Sjögren's syndrome in patients with systemic lupus erythematosus (SLE). Relation to anti-SS-A and anti-SS-B autoantibodies. Scand J Rheumatol Suppl. 1986;61:166–169. [PubMed] [Google Scholar]
  27. Jonsson H., Nived O., Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 1989 May;68(3):141–150. [PubMed] [Google Scholar]
  28. Jonsson R., Bratthall D., Nyberg G. Histologic and sialochemical findings indicating sicca syndrome in patients with systemic lupus erythematosus. Oral Surg Oral Med Oral Pathol. 1982 Dec;54(6):635–639. doi: 10.1016/0030-4220(82)90076-7. [DOI] [PubMed] [Google Scholar]
  29. Krupp L. B., LaRocca N. G., Muir J., Steinberg A. D. A study of fatigue in systemic lupus erythematosus. J Rheumatol. 1990 Nov;17(11):1450–1452. [PubMed] [Google Scholar]
  30. Kvien T. K., Glennås A., Knudsrød O. G., Smedstad L. M., Mowinckel P., Førre O. The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey. Scand J Rheumatol. 1997;26(6):412–418. doi: 10.3109/03009749709065712. [DOI] [PubMed] [Google Scholar]
  31. Moutsopoulos H. M., Klippel J. H., Pavlidis N., Wolf R. O., Sweet J. B., Steinberg A. D., Chu F. C., Tarpley T. M. Correlative histologic and serologic findings of sicca syndrome in patients with systemic lupus erythematosus. Arthritis Rheum. 1980 Jan;23(1):36–40. doi: 10.1002/art.1780230107. [DOI] [PubMed] [Google Scholar]
  32. Moutsopoulos H. M., Webber B. L., Vlagopoulos T. P., Chused T. M., Decker J. L. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med. 1979 May;66(5):733–736. doi: 10.1016/0002-9343(79)91110-0. [DOI] [PubMed] [Google Scholar]
  33. Nossent J. C., Swaak A. J. Systemic lupus erythematosus VII: frequency and impact of secondary Sjøgren's syndrome. Lupus. 1998;7(4):231–234. doi: 10.1191/096120398678920046. [DOI] [PubMed] [Google Scholar]
  34. Osial T. A., Jr, Whiteside T. L., Buckingham R. B., Singh G., Barnes E. L., Pierce J. M., Rodnan G. P. Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis. Arthritis Rheum. 1983 Apr;26(4):500–508. doi: 10.1002/art.1780260408. [DOI] [PubMed] [Google Scholar]
  35. Paschides C. A., Kitsios G., Karakostas K. X., Psillas C., Moutsopoulos H. M. Evaluation of tear break-up time, Schirmer's-I test and rose bengal staining as confirmatory tests for keratoconjunctivitis sicca. Clin Exp Rheumatol. 1989 Mar-Apr;7(2):155–157. [PubMed] [Google Scholar]
  36. Pedersen W., Schubert M., Izutsu K., Mersai T., Truelove E. Age-dependent decreases in human submandibular gland flow rates as measured under resting and post-stimulation conditions. J Dent Res. 1985 May;64(5):822–825. doi: 10.1177/00220345850640050801. [DOI] [PubMed] [Google Scholar]
  37. Pincus T., Summey J. A., Soraci S. A., Jr, Wallston K. A., Hummon N. P. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983 Nov;26(11):1346–1353. doi: 10.1002/art.1780261107. [DOI] [PubMed] [Google Scholar]
  38. Rhodus N. L., Johnson D. K. The prevalence of oral manifestations of systemic lupus erythematosus. Quintessence Int. 1990 Jun;21(6):461–465. [PubMed] [Google Scholar]
  39. Schiødt M. Oral manifestations of lupus erythematosus. Int J Oral Surg. 1984 Apr;13(2):101–147. doi: 10.1016/s0300-9785(84)80079-4. [DOI] [PubMed] [Google Scholar]
  40. Seal D. V. The effect of ageing and disease on tear constituents. Trans Ophthalmol Soc U K. 1985;104(Pt 4):355–362. [PubMed] [Google Scholar]
  41. Smolen J. S., Strand V., Cardiel M., Edworthy S., Furst D., Gladman D., Gordon C., Isenberg D. A., Klippel J. H., Petri M. Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains. J Rheumatol. 1999 Feb;26(2):504–507. [PubMed] [Google Scholar]
  42. Sreebny L. M., Schwartz S. S. A reference guide to drugs and dry mouth. Gerodontology. 1986 Autumn;5(2):75–99. doi: 10.1111/j.1741-2358.1986.tb00055.x. [DOI] [PubMed] [Google Scholar]
  43. Sreebny L. M., Valdini A. Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol. 1988 Oct;66(4):451–458. doi: 10.1016/0030-4220(88)90268-x. [DOI] [PubMed] [Google Scholar]
  44. Sreebny L. M., Valdini A., Yu A. Xerostomia. Part II: Relationship to nonoral symptoms, drugs, and diseases. Oral Surg Oral Med Oral Pathol. 1989 Oct;68(4):419–427. doi: 10.1016/0030-4220(89)90140-0. [DOI] [PubMed] [Google Scholar]
  45. Sutcliffe N., Stoll T., Pyke S., Isenberg D. A. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (SS), and primary SS. J Rheumatol. 1998 Jan;25(1):63–68. [PubMed] [Google Scholar]
  46. Talal N. Sjögren's syndrome: historical overview and clinical spectrum of disease. Rheum Dis Clin North Am. 1992 Aug;18(3):507–515. [PubMed] [Google Scholar]
  47. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  48. Uhlig T., Kvien T. K., Glennås A., Smedstad L. M., Førre O. The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol. 1998 Jun;25(6):1078–1084. [PubMed] [Google Scholar]
  49. Uhlig T., Kvien T. K., Jensen J. L., Axéll T. Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis. 1999 Jul;58(7):415–422. doi: 10.1136/ard.58.7.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Utset T. O., Golden M., Siberry G., Kiri N., Crum R. M., Petri M. Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjögren's syndrome. J Rheumatol. 1994 Nov;21(11):2039–2045. [PubMed] [Google Scholar]
  51. Van Bijsterveld O. P. Diagnosis and differential diagnosis of keratoconjunctivitis sicca associated with tear gland degeneration. Clin Exp Rheumatol. 1990 Jul-Aug;8 (Suppl 5):3–6. [PubMed] [Google Scholar]
  52. Vitali C., Bombardieri S., Moutsopoulos H. M., Balestrieri G., Bencivelli W., Bernstein R. M., Bjerrum K. B., Braga S., Coll J., de Vita S. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993 Mar;36(3):340–347. doi: 10.1002/art.1780360309. [DOI] [PubMed] [Google Scholar]
  53. Vitali C., Moutsopoulos H. M., Bombardieri S. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis. 1994 Oct;53(10):637–647. doi: 10.1136/ard.53.10.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Ware J. E., Jr, Sherbourne C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473–483. [PubMed] [Google Scholar]
  55. van Bijsterveld O. P. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969 Jul;82(1):10–14. doi: 10.1001/archopht.1969.00990020012003. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES